ITCI LOSS NOTICE: Rosen Law Firm Reminds Intra-Cellular Therapies, Inc. Investors of Important Deadline in
First Filed Class Action
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Intra-Cellular Therapies, Inc. securities (NASDAQ:
ITCI) from August 12, 2014 through April 28, 2017, inclusive (the “Class Period”) of the important July 11, 2017 lead plaintiff
deadline in the first filed class action commenced by Rosen Law Firm. The lawsuit seeks to recover damages for Intra-Cellular
Therapies investors under the federal securities laws.
To join the Intra-Cellular Therapies class action, go to http://www.rosenlegal.com/cases-1111.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at
866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU
RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to
disclose that: (1) findings related to toxicity in animals treated with lumateperone (ITI-007) were observed; (2) these findings
posed an additional safety concern regarding lumateperone; and (3) as a result, Intra-Cellular Therapies’s public statements were
materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors
suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than
July 11, 2017. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-1111.html or to discuss your rights or interests regarding this class action,
please contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or kchan@rosenlegal.com.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm. Attorney Advertising. Prior results do not guarantee a similar outcome.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder
derivative litigation. Since 2014, Rosen Law Firm has been ranked #2 in the nation by Institutional Shareholder Services for the
number of securities class action settlements annually obtained for investors.
The Rosen Law Firm, P.A.
Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: 212-686-1060
Toll Free: 866-767-3653
Fax: 212-202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
kchan@rosenlegal.com
www.rosenlegal.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170518006187/en/